Skip to main content

ORIGINAL RESEARCH article

Front. Immunol., 09 October 2020
Sec. Cancer Immunity and Immunotherapy
Volume 11 - 2020 | https://doi.org/10.3389/fimmu.2020.02026

RETRACTED: Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway

Retracted

A retraction of this article was approved in:

  1. Retraction: Cancer-associated fibroblasts-derived exosomes suppress immune cell function in breast cancer via the miR-92/PD-L1 pathway

    1. Read retraction
\r\nDongwei DouDongwei Dou1Xiaoyang RenXiaoyang Ren2Mingli HanMingli Han1Xiaodong XuXiaodong Xu1Xin GeXin Ge1Yuanting GuYuanting Gu1Xinxing Wang*Xinxing Wang1*
  • 1Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  • 2Department of Information, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Dou D, Ren X, Han M, Xu X, Ge X, Gu Y and Wang X (2020) Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway. Front. Immunol. 11:2026. doi: 10.3389/fimmu.2020.02026

Received: 19 March 2020; Accepted: 27 July 2020;
Published: 09 October 2020; Retracted: 30 July 2024.

Edited by:

Dianwen Ju, Fudan University, China

Reviewed by:

Bethany Hannafon, University of Oklahoma Health Sciences Center, United States
Kawaljit Kaur, University of California, Los Angeles, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.